Healthcare Value Capital as of March 31, 2016
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 23 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biosante Pharmaceuticals (ANIP) | 19.5 | $13M | 395k | 33.66 | |
| Albany Molecular Research | 10.2 | $6.9M | 452k | 15.29 | |
| DepoMed | 9.2 | $6.3M | 450k | 13.93 | |
| Pfizer (PFE) | 7.6 | $5.2M | 175k | 29.64 | |
| Spdr S&p 500 Etf (SPY) | 7.5 | $5.1M | 25k | 205.52 | |
| CryoLife (AORT) | 7.1 | $4.8M | 450k | 10.75 | |
| Quest Diagnostics Incorporated (DGX) | 6.9 | $4.7M | 66k | 71.46 | |
| Qlt | 6.6 | $4.5M | 2.3M | 1.99 | |
| Ultra Short Russell 2000 | 4.3 | $2.9M | 75k | 38.76 | |
| Allergan | 3.9 | $2.7M | 10k | 268.10 | |
| Proshares Tr ultsh nasd biot | 3.2 | $2.2M | 50k | 43.56 | |
| GlaxoSmithKline | 3.0 | $2.0M | 50k | 40.56 | |
| Eagle Pharmaceuticals (EGRX) | 3.0 | $2.0M | 50k | 40.50 | |
| Sagent Pharmaceuticals | 1.5 | $1.0M | 85k | 12.17 | |
| Aralez Pharmaceuticals | 1.4 | $976k | 275k | 3.55 | |
| Lannett Company | 1.3 | $897k | 50k | 17.94 | |
| Cytokinetics (CYTK) | 1.0 | $705k | 100k | 7.05 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $559k | 20k | 27.95 | |
| Fibrocell Science | 0.5 | $369k | 148k | 2.50 | |
| Zogenix | 0.4 | $294k | 32k | 9.23 | |
| Sorrento Therapeutics (SRNEQ) | 0.4 | $269k | 50k | 5.38 | |
| Apricus Bioscience | 0.4 | $255k | 440k | 0.58 | |
| Sunesis Pharmaceuticals | 0.1 | $81k | 150k | 0.54 |
